In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s resubmission of its BLA for Awiqli, the FDA’s approval of Kedrion’s Qivigy for primary humoral immunodeficiency, and Eli Lilly’s decision to halt development of a muscle-preserving weight-loss therapy.

In today’s Pharmaceutical Executive Daily, we cover AbbVie’s new API manufacturing site in Illinois, AstraZeneca’s plan to harmonize its global stock exchange listings, and reports that President Trump will announce a government-run direct-to-patient drug purchasing website.

This episode examines how trauma shapes and disrupts dreams. Traumatic experiences leave deep marks in the brain’s memory and emotion centers, often producing nightmares that replay painful events or symbolize unresolved fear. For people with PTSD, these nightmares can feel relentless, fueling anxiety and sleep disruption.At the same time, dreams hold the potential for healing. Techniques like Imagery Rehearsal Therapy, lucid dreaming, and dream sharing in therapy can help survivors reshape

In today’s Pharmaceutical Executive Daily, we cover the impact of Novo Nordisk layoffs on its hometown in Denmark, GSK’s appointment of Luke Miels as its next CEO, and the FDA’s approval of Regeneron’s Evkeeza for children with homozygous familial hypercholesterolemia.

Adam Smith narrates his blog written for Dementia Researcher. In this blog Adam explores the link between music and focus, blending science with personal experience to create a reliable study playlist. He explains why lyrics distract, how tempo influences concentration, and the value of structure in building habits. His playlist, built around ambient piano, lo-fi instrumentals, and calming endings, has become a ritual that signals time to work. The blog encourages readers to experiment with sounds

This episode focuses on survival strategies in the jungle, an environment filled with both resources and hidden dangers. Constant moisture and humidity make staying dry difficult, leading to infections and damaged gear. Listeners are advised to dry clothing when possible, protect fire-starting tools, and air out feet to prevent fungal issues.Insects are highlighted as a major threat, spreading diseases like malaria and dengue. Protection includes covering skin, using smoke as a repellent, and

In this episode we ask ourselves: on whose terms and for whose benefit am I living my wild and precious life?[0.01] Intro [0.41] Chelle reads the storybook [1.30] Evie guides listeners through the tool Take A Butterfly Hug. [3.25] Outro This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit michellemcquaid.substack.com

Opinión sobre las actitudes, creencias y obligaciones en el contexto laboral y académico.

In today’s Pharmaceutical Executive Daily, we cover the White House’s push for a Most Favored Nation drug pricing model, the FDA’s approval of Eli Lilly’s Inluriyo for ESR1-mutated metastatic breast cancer, and President Trump’s call for steep tariffs on branded pharmaceuticals

Moving from bright summer days, to crisper fall days, from deep greens into oranges and reds in fall. This is a turbulent period of transition, restlessness, and melancholia: fall.Lots of us feel restless, more anxious, up in their heads a lot. September is a typical month where everyone goes back to school. Childhood memories of our returning to school appear, making us anxious and unconsciously competitive. If you have children of your own; you might get triggered by them, reenact, and relive

Send us a text The FDA is cracking down — hard — on misleading drug advertising across TV, social media, and digital platforms. Why? Too many ads are pushing benefits while burying risks — or skipping fair balance entirely. Influencer campaigns, compounded drug promos, and telehealth ads are under the microscope. As a result, we’ve seen hundreds of warning letters and cease-and-desist letters having already been issued. In this Quality Grind Short, Mike talks about ways to prevent your produc...

In today’s Pharmaceutical Executive Daily, we cover Glenmark’s billion-dollar exclusive licensing deal with Hengrui, Harmony Biosciences’ trial setback for Zygel, and the CDC’s unanimous vote to broaden COVID-19 vaccine recommendations.